Symbol: |
DGCR6L
|
Description: |
DiGeorge syndrome critical region gene 6-like [Source:HGNC Symbol;Acc:18551]
|
Location: |
Chr22:20301799-20307603[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:351
Gene |
Compound |
Gen_sig |
Exp_pattern |
DGCR6L |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.014 |
Down |
DGCR6L |
NSC 166382 |
0.01 |
Down |
DGCR6L |
NSC 168197 |
0.01 |
Down |
DGCR6L |
Bromocriptine methanesulfonate |
0.04 |
Down |
DGCR6L |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.013 |
Down |
DGCR6L |
9-METHOXYCAMPTOTHECIN |
0.035 |
Down |
DGCR6L |
NSC 17753 |
0.011 |
Down |
DGCR6L |
2-Imidazoline-1-ethanol, .alpha.,4,4-trimethyl-2-undecyl- |
0.018 |
Down |
DGCR6L |
Hydrazinecarbothioamide, 2,2'-(1,5-dimethyl-1,5-pentanediylidene)bis[N-methyl- |
0.03 |
Down |
DGCR6L |
3-(2-PYRIDYL)-ACRYLOPHENONE |
0.045 |
Down |
DGCR6L |
NSC 201902 |
0.023 |
Down |
DGCR6L |
5-CHLORO-6-[[(3,4-DICHLOROPHENYL)AMINO]METHYL]-2,4-QUINOZOLINEDIAMINE |
0.042 |
Down |
DGCR6L |
1,8-Octanediamine, N,N'-di-9-acridinyl- |
0.003 |
Down |
DGCR6L |
NSC 227265 |
0.004 |
Down |
DGCR6L |
NSC 23416 |
0.03 |
Down |
Expression pattern: Sensitivity / Resistance
Total:24 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:2
SNP |
Gene |
SNP_location |
SNP_allele |
rs76938264 |
DGCR6L |
Chr22:20301800 |
T/G |
rs183077953 |
DGCR6L |
Chr22:20302006 |
A/G |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:34
Total:3 Current:1
[First] [Prev]  Next Last 
|